Trastuzumab Biosimilars Market Estimations (2025 - 2035)
The trastuzumab biosimilars market covers biosimilars referencing Herceptin (trastuzumab), including intravenous lyophilised products and emerging subcutaneous trastuzumab-hyaluronidase biosimilars, for HER2-positive early and metastatic breast cancer and metastatic gastric and gastroesophageal junction cancer, supplied to hospitals and oncology clinics.
📄Report ID:2524
|
📊Format: Databook
|
📅Published: 19 November 2026
|
⚡Delivery: Immediate